Tenogenic Differentiation and Musculoskeletal Applications Another potential application for differentiation enhancement lies in tenogenic differentiation
& Holscher, C
Annals of Internal Medicine , 178 (2), 199217
Small molecules as therapeutic drugs for Alzheimers disease
As a result, the MACE event rate varied substantially for participants assigned to placebo, being greatest in EMPA-REG OUTCOME (43.9 per 1,000 patient-years), followed by CREDENCE (38.7 per 1,000 patient-years), CANVAS (31.5 per 1,000 patient-years), and finally DECLARE-TIMI 58 (24.2 per 1,000 patient-years)
Aqualyx , with its clinically validated cytolytic mechanism , offers more predictable, scientifically supported results